Analysis | Metabolite Name | Measured Value | Units | Treatment | Timepoint |
---|---|---|---|---|---|
GCMS Positive ion mode | C16:0 | 39.4 | nM | Early ITT Infusion Study | 60 mins |
GCMS Positive ion mode | C16:0 | 45.4 | nM | Early ITT Infusion Study | 60 mins |
GCMS Positive ion mode | C16:0 | 45.9 | nM | Late ITT Infusion Study | 10 mins |
GCMS Positive ion mode | C16:0 | 47.4 | nM | GLP1/Late GTT | 120 mins |
GCMS Positive ion mode | C16:0 | 50.2 | nM | Early ITT Infusion Study | 60 mins |
GCMS Positive ion mode | C16:0 | 56.2 | nM | GLP1/Late GTT | 30 mins |
GCMS Positive ion mode | C16:0 | 57.4 | nM | Early ITT Infusion Study | 30 mins |
GCMS Positive ion mode | C16:0 | 58 | nM | Late ITT Infusion Study | 30 mins |
GCMS Positive ion mode | C16:0 | 60.1 | nM | GLP1/Late GTT | 60 mins |
GCMS Positive ion mode | C16:0 | 61.4 | nM | GLP1/Late GTT | 0 mins |
GCMS Positive ion mode | C16:0 | 62.5 | nM | GLP1/Late GTT | 0 mins |
GCMS Positive ion mode | C16:0 | 62.8 | nM | Late ITT Infusion Study | 30 mins |
GCMS Positive ion mode | C16:0 | 64.9 | nM | GLP1/Late GTT | 10 mins |
GCMS Positive ion mode | C16:0 | 72 | nM | Late ITT Infusion Study | 30 mins |
GCMS Positive ion mode | C16:0 | 76.8 | nM | GLP1/Late GTT | 10 mins |
GCMS Positive ion mode | C16:0 | 82.5 | nM | GLP1/Late GTT | 10 mins |
GCMS Positive ion mode | C16:0 | 83.2 | nM | Late ITT Infusion Study | 30 mins |
GCMS Positive ion mode | C16:0 | 86.2 | nM | GLP1/Late GTT | 30 mins |
GCMS Positive ion mode | C16:0 | 88 | nM | Late ITT Infusion Study | 30 mins |
GCMS Positive ion mode | C16:0 | 92.1 | nM | Late ITT Infusion Study | 10 mins |
GCMS Positive ion mode | C16:0 | 92.2 | nM | Early ITT Infusion Study | 30 mins |
GCMS Positive ion mode | C16:0 | 92.3 | nM | Late ITT Infusion Study | 0 mins |
GCMS Positive ion mode | C16:0 | 96.1 | nM | GLP1/Late GTT | 0 mins |
GCMS Positive ion mode | C16:0 | 96.2 | nM | Early ITT Infusion Study | 60 mins |
GCMS Positive ion mode | C16:0 | 96.7 | nM | GLP1/Late GTT | 120 mins |
GCMS Positive ion mode | C16:0 | 98 | nM | Early ITT Infusion Study | 10 mins |
GCMS Positive ion mode | C16:0 | 99 | nM | GLP1/Late GTT | 0 mins |
GCMS Positive ion mode | C16:0 | 104 | nM | Early ITT Infusion Study | 10 mins |
GCMS Positive ion mode | C16:0 | 104 | nM | GLP1/Late GTT | 120 mins |
GCMS Positive ion mode | C16:0 | 108 | nM | GLP1/Late GTT | 60 mins |
GCMS Positive ion mode | C16:0 | 109 | nM | Late ITT Infusion Study | 120 mins |
GCMS Positive ion mode | C16:0 | 118 | nM | GLP1/Late GTT | 0 mins |
GCMS Positive ion mode | C16:0 | 119 | nM | Early ITT Infusion Study | 30 mins |
GCMS Positive ion mode | C16:0 | 121 | nM | Late ITT Infusion Study | 60 mins |
GCMS Positive ion mode | C16:0 | 125 | nM | GLP1/Late GTT | 0 mins |
GCMS Positive ion mode | C16:0 | 127 | nM | Late ITT Infusion Study | 120 mins |
GCMS Positive ion mode | C16:0 | 130 | nM | Early ITT Infusion Study | 120 mins |
GCMS Positive ion mode | C16:0 | 138 | nM | GLP1/Late GTT | 10 mins |
GCMS Positive ion mode | C16:0 | 138 | nM | GLP1/Late GTT | 60 mins |
GCMS Positive ion mode | C16:0 | 144 | nM | GLP1/Late GTT | 0 mins |
GCMS Positive ion mode | C16:0 | 146 | nM | GLP1/Late GTT | 120 mins |
GCMS Positive ion mode | C16:0 | 155 | nM | GLP1/Late GTT | 30 mins |
GCMS Positive ion mode | C16:0 | 157 | nM | GLP1/Late GTT | 30 mins |
GCMS Positive ion mode | C16:0 | 161 | nM | GLP1/Late GTT | 10 mins |
GCMS Positive ion mode | C16:0 | 162 | nM | Early ITT Infusion Study | 120 mins |
GCMS Positive ion mode | C16:0 | 163 | nM | GLP1/Late GTT | 30 mins |
GCMS Positive ion mode | C16:0 | 166 | nM | Late ITT Infusion Study | 10 mins |
GCMS Positive ion mode | C16:0 | 171 | nM | Late ITT Infusion Study | 120 mins |
GCMS Positive ion mode | C16:0 | 174 | nM | GLP1/Late GTT | 30 mins |
GCMS Positive ion mode | C16:0 | 174 | nM | Late ITT Infusion Study | 10 mins |
GCMS Positive ion mode | C16:0 | 178 | nM | Early ITT Infusion Study | 120 mins |
GCMS Positive ion mode | C16:0 | 181 | nM | Late ITT Infusion Study | 60 mins |
GCMS Positive ion mode | C16:0 | 191 | nM | GLP1/Late GTT | 30 mins |
GCMS Positive ion mode | C16:0 | 191 | nM | Late ITT Infusion Study | 60 mins |
GCMS Positive ion mode | C16:0 | 192 | nM | GLP1/Late GTT | 10 mins |
GCMS Positive ion mode | C16:0 | 192 | nM | Late ITT Infusion Study | 60 mins |
GCMS Positive ion mode | C16:0 | 194 | nM | GLP1/Late GTT | 120 mins |
GCMS Positive ion mode | C16:0 | 195 | nM | GLP1/Late GTT | 10 mins |
GCMS Positive ion mode | C16:0 | 196 | nM | Early ITT Infusion Study | 120 mins |
GCMS Positive ion mode | C16:0 | 197 | nM | GLP1/Late GTT | 10 mins |
GCMS Positive ion mode | C16:0 | 199 | nM | Late ITT Infusion Study | 0 mins |
GCMS Positive ion mode | C16:0 | 203 | nM | Early ITT Infusion Study | 0 mins |
GCMS Positive ion mode | C16:0 | 203 | nM | Late ITT Infusion Study | 0 mins |
GCMS Positive ion mode | C16:0 | 204 | nM | Early ITT Infusion Study | 30 mins |
GCMS Positive ion mode | C16:0 | 204 | nM | GLP1/Late GTT | 120 mins |
GCMS Positive ion mode | C16:0 | 206 | nM | GLP1/Late GTT | 0 mins |
GCMS Positive ion mode | C16:0 | 206 | nM | Late ITT Infusion Study | 0 mins |
GCMS Positive ion mode | C16:0 | 208 | nM | GLP1/Late GTT | 30 mins |
GCMS Positive ion mode | C16:0 | 209 | nM | Early ITT Infusion Study | 0 mins |
GCMS Positive ion mode | C16:0 | 209 | nM | GLP1/Late GTT | 60 mins |
GCMS Positive ion mode | C16:0 | 211 | nM | Late ITT Infusion Study | 10 mins |
GCMS Positive ion mode | C16:0 | 212 | nM | GLP1/Late GTT | 60 mins |
GCMS Positive ion mode | C16:0 | 215 | nM | GLP1/Late GTT | 0 mins |
GCMS Positive ion mode | C16:0 | 216 | nM | GLP1/Late GTT | 30 mins |
GCMS Positive ion mode | C16:0 | 220 | nM | GLP1/Late GTT | 60 mins |
GCMS Positive ion mode | C16:0 | 224 | nM | GLP1/Late GTT | 60 mins |
GCMS Positive ion mode | C16:0 | 228 | nM | GLP1/Late GTT | 30 mins |
GCMS Positive ion mode | C16:0 | 234 | nM | GLP1/Late GTT | 120 mins |
GCMS Positive ion mode | C16:0 | 237 | nM | GLP1/Late GTT | 120 mins |
GCMS Positive ion mode | C16:0 | 238 | nM | Early ITT Infusion Study | 0 mins |
GCMS Positive ion mode | C16:0 | 251 | nM | GLP1/Late GTT | 0 mins |
GCMS Positive ion mode | C16:0 | 253 | nM | Early ITT Infusion Study | 10 mins |
GCMS Positive ion mode | C16:0 | 254 | nM | Early ITT Infusion Study | 30 mins |
GCMS Positive ion mode | C16:0 | 257 | nM | GLP1/Late GTT | 120 mins |
GCMS Positive ion mode | C16:0 | 266 | nM | GLP1/Late GTT | 30 mins |
GCMS Positive ion mode | C16:0 | 273 | nM | GLP1/Late GTT | 60 mins |
GCMS Positive ion mode | C16:0 | 276 | nM | Early ITT Infusion Study | 10 mins |
GCMS Positive ion mode | C16:0 | 276 | nM | GLP1/Late GTT | 30 mins |
GCMS Positive ion mode | C16:0 | 278 | nM | GLP1/Late GTT | 60 mins |
GCMS Positive ion mode | C16:0 | 285 | nM | GLP1/Late GTT | 60 mins |
GCMS Positive ion mode | C16:0 | 286 | nM | GLP1/Late GTT | 120 mins |
GCMS Positive ion mode | C16:0 | 287 | nM | Early ITT Infusion Study | 120 mins |
GCMS Positive ion mode | C16:0 | 296 | nM | GLP1/Late GTT | 60 mins |
GCMS Positive ion mode | C16:0 | 300 | nM | Early ITT Infusion Study | 10 mins |
GCMS Positive ion mode | C16:0 | 300 | nM | Late ITT Infusion Study | 120 mins |
GCMS Positive ion mode | C16:0 | 303 | nM | Late ITT Infusion Study | 120 mins |
GCMS Positive ion mode | C16:0 | 304 | nM | GLP1/Late GTT | 60 mins |
GCMS Positive ion mode | C16:0 | 330 | nM | GLP1/Late GTT | 120 mins |
GCMS Positive ion mode | C16:0 | 358 | nM | GLP1/Late GTT | 120 mins |
GCMS Positive ion mode | C16:0 | 366 | nM | GLP1/Late GTT | 10 mins |
GCMS Positive ion mode | C16:0 | 383 | nM | GLP1/Late GTT | 10 mins |
GCMS Positive ion mode | C16:0 | 389 | nM | GLP1/Late GTT | 10 mins |
GCMS Positive ion mode | C16:0 | 417 | nM | GLP1/Late GTT | 10 mins |
GCMS Positive ion mode | C16:0 | 421 | nM | GLP1/Late GTT | 0 mins |
GCMS Positive ion mode | C16:0 | 425 | nM | Early ITT Infusion Study | 0 mins |
GCMS Positive ion mode | C16:0 | 539 | nM | GLP1/Late GTT | 0 mins |